WVE
Wave Life Sciences·NASDAQ
--
--(--)
--
--(--)
4.58 / 10
Netural
Fund flow analysis shows a positive 7.4/10 score, with overall inflow ratios below 0.5 yet still indicating liquidity support across block, small, medium, large, and extra-large trades. Analyst coverage is overwhelmingly bullish (Strong Buy 54.5%, Buy 45.5% from 11 analysts), though historical win rates vary widely (0-100%). The market-weighted rating of 1.76 is low, and current price decline (-5.2%) contrasts with optimistic expectations, warranting vigilance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
55%
Buy
45%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-19
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of WVE?
- WVE holds a Bearish analyst rating, with 55% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.58/10 (Netural).
